UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: November 10, 2022 4:00 P.M.
Form: S-1
CIK: 0001815974
Company Name: Anebulo Pharmaceuticals, Inc.
File Number: 333-268113